Lipocine (LPCN) 10-Q2024 Q1 Quarterly report

Filed: 9 May 24, 6:06am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: adjunct, ago, agonist, aid, Alliance, alpha, ameliorate, America, amplify, anabolic, antioxidant, ASU, attenuate, aware, background, Biol, BMI, brand, Canada, Caterson, cessation, clarifying, CODM, cohort, collateral, compelling, concomitant, daytime, DH, diet, discontinuation, dressing, drinking, dyslipidemia, eating, ED, EL, essential, etiology, eventually, exceeded, Exp, fattening, fewer, Flynn, GABA, GABAergic, Gerbasi, Giovannucci, Gordon, GSL, head, highlighting, Hubbard, incretin, inflow, intervention, interview, knee, Kyperkinet, lag, lean, Lee, LM, lose, losing, lost, Maker, manifest, Mapping, MDS, Med, mimetic, moderate, Morgan, Mov, nata, necessitate, neuromuscular, North, NY, Ottman, overshoot, overweight, play, pouring, preclinical, PRN, pro, prone, proportion, psychological, rebound, recognition, recovery, Reportedly, retrospectively, role, shaking, Silver, Stanley, superior, sustainably, switched, Thun, tremor, unfavorable, unwanted, Verity, voice, vulnerable, wind, writing

Removed: ABPM, accessibility, acquisition, adhere, affordability, agreeing, alleging, ambulatory, analyst, annum, answered, asserted, Bank, bar, black, bond, bore, borrowed, box, breast, Bulletin, capitalization, charge, claim, clarification, comorbid, component, conference, consecutive, consisted, construction, continuing, Council, coverage, deadline, declining, deferral, delisting, demanding, dispute, economy, effort, Encap, Exhibit, feedback, feeding, finalized, float, foregoing, fraud, fraudulent, governance, Harmonisation, hiring, ICH, infringement, inpatient, Interference, International, introduction, invalid, invalidity, inventory, investigate, JATENZO, Journal, lend, listed, listing, loan, maintenance, manufacturer, monthly, national, newborn, nonalcoholic, owing, PAM, paper, penny, phlebotomy, PREA, preempted, Prespecified, Prime, privacy, publication, purport, quotation, ready, receivable, recruitment, reference, refine, regulate, regulating, relation, representing, requested, rest, SAB, scale, scaling, scheduling, sedation, separation, setting, Silicon, simplified, solicited, statute, stigma, strained, streamline, Street, stringent, successor, supervised, surviving, suspicion, SVB, symbol, Technical, trademark, twelve, unrelated, USPTO, Valley, Wall, warning, world

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

LPCN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION

In connection with the Quarterly Report on Form 10-Q of Lipocine Inc. (the “Corporation”) for the quarter ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Mahesh V. Patel, Principal Financial Officer of the Corporation, hereby certifies, pursuant to Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

Dated: May 9, 2024	/s/ Mahesh V. Patel
	Mahesh V. Patel
	(Principal Financial Officer)